What Has Been the Progress and Growth of the Plasmanate Market in Recent Years?
The plasmanate market has seen considerable growth due to a variety of factors.
• In recent times, the plasmanate market has seen a high compound annual growth rate (HCAGR) of XX. The market size which was at $XX million in 2024 is anticipated to escalate to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%.
Factors behind this upsurge during the historic period include an increasing number of trauma incidents worldwide, the expansion of emergency medical services, higher prevalence of surgical procedures, augmented healthcare expenditure, and a boost in global healthcare funding.
What Can Be Expected from the Plasmanate Market Size In The Coming Years?
The plasmanate market is expected to maintain its strong growth trajectory in upcoming years.
• The market for plasmanate is anticipated to witness a compound annual growth rate (CAGR) of XX% and expand to $XX million by 2029.
Several factors can potentially drive this growth during the forecast period such as the increased occurrence of chronic diseases, a surge in autoimmune disease cases, the enlargement of plasma donation facilities, the evolution of medical tourism, and the growing number of mass casualty incidents. Key trends during this forecast period are set to be the incorporation of artificial intelligence in plasma production, the creation of pathogen-free plasma solutions, progress in the stabilization of plasma proteins, the application of blockchain technology in managing the plasma supply chain, and the emergence of hybrid plasma solutions.
What Are The Key Drivers Fueling Growth In The Plasmanate Market?
The plasmanate market is anticipated to expand due to the increasing number of trauma cases. Trauma cases refer to severe physical or emotional injuries produced by an external force or a traumatic situation, necessitating immediate medical care, surgery, rehabilitation, and mental health services for recovery. The rise in such cases can be attributed to higher incident rates of accidents, urban living conditions exposing individuals to more dangerous circumstances, and changes in lifestyle patterns like more risk-taking behavior and substance abuse. Patients with trauma may experience hypovolemic shock due to severe blood loss, which necessitates plasma transfusion to replenish the circulating blood volume and maintain adequate blood pressure. For example, a report released by Netherlands-based information services corporation, Wolters Kluwer Health Inc. in June 2022, revealed that approximately 22,000 major trauma cases are reported annually in the UK over its four nations. This makes it the chief cause of mortality for both children and adults up to 45 years old. Consequently, the escalating occurrence of trauma cases is contributing to the growth of the plasmanate market.
How Is The Plasmanate Market segmented?
The plasmanate market covered in this report is segmented –
1) By Formulation: Liquid Formulations, Lyophilized Formulations
2) By Clinical Indication: Hypovolemia, Burns, Shock, Hypoproteinemia, Surgical Procedures
3) By Distribution Channel: Online Pharmacies, Wholesale Distributors
4) By End User: Hospitals, Clinical Research Laboratories
Pre-Book The Plasmanate Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Plasmanate Market?
Major companies operating in the plasmanate market are:
• Grifols Therapeutics LLC
What Is The Most Dominant Region In The Plasmanate Market?
North America was the largest region in the plasmanate market in 2024. The regions covered in the plasmanate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
